Haber Pharma Chem Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 4 Year, 18 Days
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Ebitda
- Net Worth
- Total Assets 145.72%
(FY 2022)
About Haber Pharma Chem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nishith Lakhani, Dhairya Lakhani, and Dixitkumar Patel serve as directors at the Company.
- CIN/LLPIN
U24290GJ2020PTC118860
- Company No.
118860
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Dec 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Haber Pharma Chem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nishith Lakhani  | Director | 15-Dec-2020 | Current |
| Dhairya Lakhani | Director | 15-Dec-2020 | Current |
| Dixitkumar Patel | Director | 15-Dec-2020 | Current |
Financial Performance of Haber Pharma Chem.
Haber Pharma Chem Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Haber Pharma Chem?
Unlock access to Haber Pharma Chem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Yogi Intermediates Private LimitedActive 14 years 30 daysNishith Lakhani and Dhairya Lakhani are mutual person
Ved Pharmachem Private LimitedActive 4 years 1 monthNishith Lakhani and Dhairya Lakhani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Haber Pharma Chem?
Haber Pharma Chem has a workforce of 0 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Haber Pharma Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Haber Pharma Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
